Estadístiques de Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients

Visites totals

views
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients 1

Visites totals per mes

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 1
March 2025 0
April 2025 0

Visites al fitxer

views
Brahmer_ejc_safe.pdf 24
Brahmer_ejc_safe.pdf(legacy) 3